Dynasil Corporation of America (DYSL)

[jockinmikeg]

After much cost averaging, on the right side of the trade and holding because I think the contracts research and optics are growing and I still don't think much value is assigned to biomedical in the stock price. Any positive XCede trial news and this breaks out to new 52-wk highs. We have 2 reputable investors/partners in Mayo Clinic and Cook who know a whole lot more about XCede than we do and they apparently like the numbers. Last contact w/co., was told the Xcede trial is "on schedule" for dosing patients this year. 3 of 9 required toxicology studies are underway along with QC details and other necessary steps by Cook Biotech. They are happy with their progress. So am I, after Xcede sitting on the shelf so long; it's progress. IMO the lack of progress til now is why the market up to this point has seen XCede as dead money. Any clinical progress with it will increase investor interest and add value to that subsidiary.

Some complain they are not shareholder-friendly, but my emails always were answered.